Signal Pharmaceuticals, Inc.

4550 Towne Centre Court,
San Diego, Colorado 92121
United States,

Signal Pharmaceuticals, Inc., a privately held San Diego-based biopharmaceutical company focused on the discovery and development of new classes of drugs that regulate genes associated with disease. Signal's technology is centered in the key areas of intracellular signaling and gene and protein regulation.

Signal Pharmaceuticals was acquired by Celgene on August 31, 2000.

Join Mergr to view all 40 acquisitions of medical products companies in 2000, including 11 acquisitions by private equity firms, and 29 by strategics.

Out of 60 sectors in the Mergr database, medical products ranked 13 in number of deals in 2000. The largest medical products acquisition in 2000 was InnerDyne - which was acquired by Tyco International for $180M.

Join Mergr to view this profile - and discover more medical products acquisitions of companies like Signal Pharmaceuticals.

What's Mergr?

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
  • 3.4K Private Equity Firms
  • 119K M&A Transactions
  • 129K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 2.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 35K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.